The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Caribou Biosciences Appoints Tina Albertson, Md, Ph D, As Chief Medical Officer
PUBLIC · CRBUAug 12, 2024•almost 2 years ago
Position
Chief Medical Officer
Company
Caribou
Tina Albertson
BerkeleyBiotechnology
Description
Caribou Biosciences, Inc. announced the appointment of Tina Albertson, MD, PhD, as chief medical officer
Company Information
Company
Caribou
Location
Berkeley, California, United States
About
Caribou is a clinical-stage biopharmaceutical company, founded by pioneers in CRISPR genome editing, leveraging our proprietary technology to develop genome-edited off-the-shelf immune cell therapies for the treatment of cancer. We believe that cell therapies are critical now and for the future of cancer therapy and that advanced genome editing is necessary to develop sophisticated cell therapies to treat a variety of malignancies. We are developing a pipeline of genome-edited, off-the-shelf CAR-T and CAR-NK cell therapies for a range of tumor types.